ÂÜÀòÂÒÂ×

Brad Smith has nearly 30 years of experience leading business and financial operations for public and private companies in the biotechnology and healthcare industry. During his career, Mr. Smith has been instrumental in raising nearly $1 billion in private and public equity and debt financing, has played a key role in business development and strategic planning functions and has successfully guided four companies through the IPO process. Prior to joining Homology, Mr. Smith served as Chief Financial Officer of Ocular Therapeutix, Inc., where he led the company’s strategic financings, including an IPO and subsequent follow-on offerings, and completed a development and commercialization deal with a major biopharmaceutical company. Previously, he served as CFO of five other companies, including OmniGuide Surgical, NeuroMetrix, Inc., SYNARC, PatientKeeper, Inc. and Focal, Inc. He is a member of the Board of Directors of Lyra Therapeutics and eGenesis. Mr. Smith holds a B.S. in Biology from Tufts University and an M.B.A. from the Whittemore School at the University of New Hampshire, and he became a Certified Public Accountant while working at Coopers & Lybrand.